Document Detail


Effects of beta adrenoceptor agonists and antagonists on adrenal catecholamine release in response to splanchnic nerve stimulation in anesthetized dogs: role of beta-1 and beta-2 adrenoceptors.
MedLine Citation:
PMID:  7791106     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The present study was performed to examine whether beta adrenoceptor agonists and antagonists modify the release of adrenal catecholamine (CA) in response to splanchnic nerve stimulation (SNS) in anesthetized dogs, in order to elucidate the beta adrenoceptor-mediated modulation of adrenal CA release. SNS at 3 Hz produced marked increases in both epinephrine and norepinephrine output determined from adrenal venous blood. Atenolol (10, 30 and 100 micrograms/kg, i.v.) and CGP20712A (10 and 30 micrograms/kg, i.v.), selective beta-1 adrenoceptor antagonists, significantly enhanced the SNS-induced increases in CA output. Neither ICI118551 (10, 30 and 100 micrograms/kg, i.v.), a selective beta-2 adrenoceptor antagonist, nor nadolol (10, 30 and 100 micrograms/kg, i.v.), a nonselective beta adrenoceptor antagonist, affected the SNS-induced increases in CA output. After the treatment with ICI118551 (100 micrograms/kg, i.v.), atenolol (10, 30 and 100 micrograms/kg, i.v.) failed to enhance the SNS-induced increases in CA output. On the other hand, neither isoproterenol (0.03 and 0.1 micrograms/kg/min, i.v.) nor the selective beta-2 adrenoceptor agonist procaterol (0.03 and 0.1 micrograms/kg/min, i.v.) affected the SNS-induced increases in CA output. After the treatment with atenolol (100 micrograms/kg, i.v.), both isoproterenol (0.03 micrograms/kg/min, i.v.) and procaterol (0.03 micrograms/kg/min, i.v.) enhanced the SNS-induced increases in CA output. The enhancing effects of isoproterenol and procaterol were abolished by ICI118551 (100 micrograms/kg, i.v.). These results indicate that activation of beta-2 adrenoceptors facilitates the SNS-evoked release of CA from the dog adrenal medulla under the condition in which beta-1 adrenoceptors are blocked, and they suggest that activation of beta-1 adrenoceptors inhibits the beta-2 adrenoceptor-mediated facilitation process of adrenal CA release.
Authors:
H Koganei; T Kimura; S Satoh
Related Documents :
6542296 - Effect of phenoxybenzamine on myocardial cell necroses and blood levels of catecholamin...
2568966 - Dose difference in beta-adrenergic blockers with intrinsic sympathomimetic action to bl...
8593256 - Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure pr...
624356 - An escape phenomenon from water and sodium retention induced by propranolol in rats.
9503376 - Use of thermoluminescent dosimetry to verify dose compensation in total body irradiation.
10709916 - Effects of preshipping vs. arrival medication with tilmicosin phosphate and feeding chl...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  273     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1995 Jun 
Date Detail:
Created Date:  1995-07-21     Completed Date:  1995-07-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1337-44     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Pharmaceutical Institute, Tohoku University, Sendai, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Glands / drug effects*,  metabolism
Adrenergic beta-Agonists / pharmacology*
Adrenergic beta-Antagonists / pharmacology*
Animals
Atenolol / pharmacology
Catecholamines / metabolism*
Dogs
Female
Imidazoles / pharmacology
Male
Receptors, Adrenergic, beta-1 / metabolism
Receptors, Adrenergic, beta-2 / metabolism
Splanchnic Nerves / drug effects*,  metabolism
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Adrenergic beta-Antagonists; 0/Catecholamines; 0/Imidazoles; 0/Receptors, Adrenergic, beta-1; 0/Receptors, Adrenergic, beta-2; 29122-68-7/Atenolol; 81015-67-0/CGP 20712A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Right heart failure impairs hepatic oxygenation and theophylline clearance in rats.
Next Document:  Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.